Place of radiotherapy in the treatment of Graves' orbitopathy

被引:37
作者
Beckendorf, V [1 ]
Maalouf, T
George, JL
Bey, P
Leclere, J
Luporsi, E
机构
[1] Ctr Alexis Vautrin, Dept Radiotherapy, F-54511 Vandoeuvre Nancy, France
[2] Ctr Alexis Vautrin, Dept Stat, F-54511 Vandoeuvre Nancy, France
[3] CHU Nancy Brabois, Dept Ophthalmol, F-54511 Vandoeuvre Nancy, France
[4] CHU Nancy Brabois, Dept Endocrinol, F-54511 Vandoeuvre Nancy, France
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1999年 / 43卷 / 04期
关键词
Graves' orbitopathy; radiotherapy;
D O I
10.1016/S0360-3016(98)00405-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The aim of this study is to evaluate the response of Graves' orbitopathy to irradiation, and to specify the prognostic factors allowing one to better define the indications of orbital radiotherapy. Methods and Materials: From 1977 to 1996, 199 patients received bilateral orbital irradiation delivering 20 Gy in 10 fractions and 2 weeks for a progressive Graves' orbitopathy, 195 patients were seen between I and 6 months after radiotherapy. The different symptoms were studied and their response to radiation was analyzed. Factors such as age, sex, evolution of thyroid disease, history of symptoms, and previous or combined treatments were analyzed, Results: The results revealed that 50 patients (26%) had a good or excellent response, 98 (50%) had a partial response, 37 (19%) were stable, 10 (5%) had a progression of disease. The signs that best responded to radiotherapy were the infiltration of soft tissues and the corneal involvement. Responses of proptosis or oculomotor disorders were more complete when these signs were not advanced at the time of treatment. Irradiation seemed to have the same efficacy when applied as first-line treatment or after failure of corticosteroids, Neither modality of treatment of hyperthyroidism nor thyroid status at the time of orbital irradiation modified the results. The best results were recorded for early or moderately advanced presentation (p = 0.05). Patients treated within a delay of 7 months after the beginning of the ophthalmopathy had better responses than patients treated later (p = 0.10), Conclusion: Radiation therapy was successful in Graves' orbitopathy by stopping the progression of disease in almost all cases, by improving the comfort of patients, by obtaining objective responses, and by avoiding surgical treatments particularly when signs were moderate. (C) 1999 Elsevier Science Inc.
引用
收藏
页码:805 / 815
页数:11
相关论文
共 52 条
[1]  
Alberti W., 1991, RADIOPATHOLOGY ORGAN, P269
[2]  
AMANO K, 1993, THERAPEUTIC PLASMAPH, V12, P83
[3]   USE OF EYE MUSCLE ANTIBODY MEASUREMENTS TO MONITOR RESPONSE TO PLASMAPHERESIS IN PATIENTS WITH THYROID-ASSOCIATED OPHTHALMOPATHY [J].
ATABAY, C ;
SCHROOYEN, M ;
ZHANG, ZG ;
SALVI, M ;
GLINOER, D ;
WALL, JR .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1993, 16 (09) :669-674
[4]   ORBITAL COBALT IRRADIATION COMBINED WITH SYSTEMIC CORTICOSTEROIDS FOR GRAVES OPHTHALMOPATHY - COMPARISON WITH SYSTEMIC CORTICOSTEROIDS ALONE [J].
BARTALENA, L ;
MARCOCCI, C ;
CHIOVATO, L ;
LADDAGA, M ;
LEPRI, G ;
ANDREANI, D ;
CAVALLACCI, G ;
BASCHIERI, L ;
PINCHERA, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 56 (06) :1139-1144
[5]   The chronology of Graves' ophthalmopathy in an incidence cohort [J].
Bartley, GB ;
Fatourechi, V ;
Kadrmas, EF ;
Jacobsen, SJ ;
Ilstrup, DM ;
Garrity, JA ;
Gorman, CA .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1996, 121 (04) :426-434
[6]   The treatment of Graves' ophthalmopathy in an incidence cohort [J].
Bartley, GB ;
Fatourechi, V ;
Kadrmas, EF ;
Jacobsen, SJ ;
Ilstrup, DM ;
Garrity, JA ;
Gorman, CA .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1996, 121 (02) :200-206
[7]   Evolution of classification systems for Graves' ophthalmopathy [J].
Bartley, GB .
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 1995, 11 (04) :229-237
[8]  
BLANK LEC, 1996, RADIOTHER ONCOL, V40, P185
[9]  
DEGROOT LJ, 1995, J CLIN ENDOCR METAB, V80, P399
[10]  
DEROSA G, 1982, CURR THER RES CLIN E, V31, P944